Hypoxia-Specific Drug Tirapazamine Does Not Abrogate Hypoxic Tumor Cells in Combination Therapy with Irinotecan and Methylselenocysteine in Well-Differentiated Human Head and Neck Squamous Cell Carcinoma A253 Xenografts

Well-differentiated hypoxic regions in head and neck squamous cell carcinoma like in A253 xenografts are avascular and, therefore, hinder drug delivery leading to drug resistance and tumor regrowth. Methylselenocysteine (MSC, 0.2 mg/mouse per day per oral for 35 days starting 7 days before the first...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bhattacharya, Arup, Tóth, Károly, Durrani, Farukh A, Cao, Shousong, Slocum, Harry K, Chintala, Sreenivasulu, Rustum, Youcef M
Format: Artigo
Langue:Inglês
Publié: Neoplasia Press Inc. 2008
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2481573/
https://ncbi.nlm.nih.gov/pubmed/18670644
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires